Spanish Registry of Autoimmune and Cholestatic Liver Diseases to Understand Their Status and Characteristics in Spain

What this Trial Is About

Researchers are compiling a registry to understand the current status of several liver diseases in Spain, including primary biliary cholangitis, autoimmune hepatitis, primary sclerosing cholangitis, and various genetic cholestatic diseases. This registry aims to gather detailed information to better characterize these conditions across the country. The study does not involve specific treatments or interventions but focuses on collecting data from patients diagnosed with these liver diseases. By registering participants, the research team hopes to analyze the prevalence and distinct features of these autoimmune and cholestatic liver diseases within the Spanish population. Participants will be asked to provide information about their diagnosis and disease characteristics. Researchers will use this data to measure the prevalence and features of these liver conditions up to the year 2025. There is no mention of additional tests or follow-up procedures, and participation involves consenting to share medical information for this registry.

Spanish Registry of Autoimmune and Cholestatic Liver Diseases (ColHai)